FDA QMSR

How to validate and implement vaporized hydrogen peroxide (VHP) sterilization under ISO 22441:2022 — FDA Established Category A recognition, process parameters, validation protocol, material compatibility, and regulatory pathway for medical device manufacturers.

Complete step-by-step guide to implementing ISO 13485:2016 from scratch. Covers all 8 clauses, documentation hierarchy, certification process (Stage 1 and Stage 2 audits), costs ($5K-$60K+), timeline (6-24 months), notified body selection, and alignment with FDA QMSR effective February 2026.

How to conduct management reviews for medical device companies per ISO 13485 Clause 5.6 and FDA QMSR — required inputs, outputs, frequency, documentation, and common audit findings.

Quality Assurance vs. Quality Control in medical device manufacturing — proactive vs. reactive, process vs. product, responsibilities, tools, org structure, and how QMSR 2026 changes the landscape. Includes FDA 21 CFR 820 and ISO 13485 alignment.

How to build and sustain a quality culture in medical device organizations — FDA QMSR Comment 27 expectations, ISO 13485 Clause 5 management responsibility, behavioral indicators, leadership practices, audit methods, and a practical framework for cultural transformation.

How to conduct quality investigations for medical devices — complaint handling, nonconformance investigation, audit finding root cause analysis, investigation methods, CAPA integration, and regulatory requirements under ISO 13485:2016, FDA 21 CFR 820, and EU MDR.

How to build a quality KPI framework for medical device companies — CAPA effectiveness, first pass yield, complaint rates, design control metrics, and cost of quality. Fully aligned with ISO 13485:2016 and FDA QMSR 2026 requirements.

How to write a quality manual that satisfies ISO 13485:2016 Clause 4.2.2 — the four mandatory elements, documentation structure, FDA QMSR considerations, common mistakes, and a detailed template outline.

Complete guide to root cause analysis for medical device companies — 5 Whys, fishbone diagrams, fault tree analysis, Pareto charts, CAPA integration, and common mistakes that lead to FDA 483 observations.

How to build and maintain a requirements traceability matrix for medical devices — linking user needs, design inputs, outputs, risk controls, verification, and validation under FDA 21 CFR 820.30, ISO 13485:2016, IEC 62304, and EU MDR.

Complete guide to training management in medical device QMS — ISO 13485 Clause 6.2 requirements, FDA QMSR expectations, effectiveness evaluation methods, electronic training systems, and audit-readiness best practices.

Complete guide to FDA 21 CFR Part 11 for medical device companies — electronic records, electronic signatures, audit trails, system validation, CSA guidance, and how Part 11 connects to ISO 13485 and the new QMSR.

Comprehensive guide to FDA and EU MDR regulations for reprocessing single-use medical devices — covering 510(k)/PMA requirements, Article 17, Common Specifications, cost savings, and the 2026 EU amendment.

How to budget for ISO 13485 certification in 2026 — consulting fees (offsite vs onsite), surveillance and recertification costs, what auditors look for, how to choose a certification body, and ISO 13485 vs ISO 9001 for medical device companies. Plus the impact of FDA's QMSR.

Clause-by-clause gap analysis checklist mapping ISO 13485:2016 to FDA's QMSR — covering terminology changes, complaint handling, labeling controls, UDI integration, record retention, and 50+ specific action items your QMS documents still need.

An independent, unbiased comparison of the top eQMS platforms for medical device companies in 2026 — covering Greenlight Guru, MasterControl, Qualio, QT9 QMS, ComplianceQuest, Arena QMS, and more. Includes pricing, features, ISO 13485 and QMSR readiness, and recommendations by company size.

A comprehensive breakdown of ISO 13485 certification costs, implementation timelines, and hidden expenses — with 2026-specific figures for certification body fees, consulting rates, surveillance audits, and cost-saving strategies for medical device companies.